Drugs

Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal”
pp. 2481-2485(5)
Author: Abrams, Ross A.

Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal”
pp. 2487-2490(4)
Authors: Ghaneh, Paula; Tudur-Smith, Catrin; Neoptolemos, John P.

Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal - The Authors' Reply
pp. 2491-2493(3)
Authors: Oettle, Helmut; Neuhaus, Peter

Potential Pharmacological Interventions in Polycystic Kidney Disease
pp. 2495-2510(16)
Authors: Masoumi, Amirali; Reed-Gitomer, Berenice; Kelleher, Catherine; Schrier, Robert W.

Crohn's Disease: A Review of Current Treatment with a Focus on Biologics
pp. 2511-2537(27)
Authors: Panés, Julián; Gomollón, Fernando; Taxonera, Carlos; Hinojosa, Joaquin; Clofent, Juan; Nos, Pilar

Pharmacotherapy for Oesophagogastric Cancer
pp. 2539-2556(18)
Authors: Jackson, Christopher; Starling, Naureen; Yu Jo Chua,; Cunningham, David

Defining the Role of Insulin Detemir in Basal Insulin Therapy
pp. 2557-2584(28)
Author: Morales, Javier

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer
pp. 2585-2607(23)
Authors: Blick, Stephanie K.A.; Scott, Lesley J.

Etanercept: A Review of its Use in the Management of Ankylosing Spondylitis and Psoriatic Arthritis
pp. 2609-2633(25)
Authors: Hoy, Sheridan M.; Scott, Lesley J.

Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis
pp. 2635-2642(8)
Authors: McCormack, Paul L.; Robinson, Dean M.; Perry, Caroline M.

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Åke Nilsson
pp. 2643-2644(2)
Authors: Nilsson, Åke

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Cosimo Prantera
pp. 2643-2644(2)
Author: Prantera, Cosimo

Imatinib: In Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
pp. 2645-2654(10)
Authors: Cross, Sarah A.; Lyseng-Williamson, Katherine A.

Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Viewpoint by Joseph Brandwein
pp. 2655-2656(2)
Author: Brandwein, Joseph

Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Viewpoint by Ronan Swords
pp. 2655-2656(2)
Author: Swords, Ronan

Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Viewpoint by Barbara Wassmann
pp. 2655-2656(2)
Author: Wassmann, Barbara